Recombinant human hyaluronidase PH20
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant human hyaluronidase PH20, covering 2025-02-20 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants [Phase 1]